Astria Therapeutics shares owned by MetLife Investment Advisors
Quarter-by-quarter ownership of Astria Therapeutics (ATXS) shares owned by MetLife Investment Advisors
from 13F filings
Historical chart of MetLife Investment Advisors investment in Astria Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Astria Therapeutics held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Astria Therapeutics by MetLife Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $134k | 18k | 7.28 |
| 2025-06-30 | $134k | 25k | 5.36 |
| 2025-03-31 | $125k | 23k | 5.34 |
| 2024-12-31 | $241k | 27k | 8.94 |
| 2024-09-30 | $297k | 27k | 11.01 |
| 2024-06-30 | $246k | 27k | 9.10 |
| 2023-12-31 | $104k | 14k | 7.68 |
| 2023-09-30 | $101k | 14k | 7.46 |
| 2023-06-30 | $113k | 14k | 8.33 |
More positions owned by MetLife Investment Advisors
View all positions for MetLife Investment Advisors